Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial
Nordic Life Science Pipeline (Canada) · Bavarian Nordic (United States) · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
59
total citations
- FWCI
- 87.72
- Percentile
- 100%
- References
- 29
Citations per year
Authors
13Topics & keywords
Topics
Keywords
- Immunogenicity
- Placebo
- Medicine
- Virus
- Virology
- Virus-like particle
- Chikungunya
- Double blind
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.